A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Public ClinicalTrials.gov record NCT02298192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Europe, North America and the United States of America. The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.
Study identification
- NCT ID
- NCT02298192
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 420 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 21, 2014 (Actual)
- Primary completion
- Dec 23, 2015 (Actual)
- Completion
- Dec 23, 2015 (Actual)
- Last update posted
- May 23, 2017
2014 – 2015
United States locations
- U.S. sites
- 40
- U.S. states
- 21
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Hamilton | Alabama | 35570 | — |
| Novo Nordisk Investigational Site | Chandler | Arizona | 85224 | — |
| Novo Nordisk Investigational Site | Glendale | Arizona | 85306-4652 | — |
| Novo Nordisk Investigational Site | Glendale | Arizona | 85308 | — |
| Novo Nordisk Investigational Site | Mesa | Arizona | 85213 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85018 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85020 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85741 | — |
| Novo Nordisk Investigational Site | Anaheim | California | 92801 | — |
| Novo Nordisk Investigational Site | Palm Springs | California | 92262 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80904 | — |
| Novo Nordisk Investigational Site | Boynton Beach | Florida | 33472 | — |
| Novo Nordisk Investigational Site | Clearwater | Florida | 33765 | — |
| Novo Nordisk Investigational Site | Hallandale | Florida | 33009 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33173 | — |
| Novo Nordisk Investigational Site | Orlando | Florida | 32801 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33603 | — |
| Novo Nordisk Investigational Site | Conyers | Georgia | 30094-5965 | — |
| Novo Nordisk Investigational Site | Blackfoot | Idaho | 83221 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46254 | — |
| Novo Nordisk Investigational Site | Crestview Hills | Kentucky | 41017-3464 | — |
| Novo Nordisk Investigational Site | Troy | Michigan | 48098 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89103 | — |
| Novo Nordisk Investigational Site | Nashua | New Hampshire | 03063 | — |
| Novo Nordisk Investigational Site | West Seneca | New York | 14224 | — |
| Novo Nordisk Investigational Site | Greensboro | North Carolina | 27408 | — |
| Novo Nordisk Investigational Site | Norman | Oklahoma | 73069 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Spartanburg | South Carolina | 29303 | — |
| Novo Nordisk Investigational Site | Humboldt | Tennessee | 38343 | — |
| Novo Nordisk Investigational Site | Kingsport | Tennessee | 37660 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77008 | — |
| Novo Nordisk Investigational Site | Katy | Texas | 77450 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78215 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78240 | — |
| Novo Nordisk Investigational Site | Newport News | Virginia | 23606 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02298192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 23, 2017 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02298192 live on ClinicalTrials.gov.